Yanjun Liu, M.D., Ph.D, has served as a member of our board of directors since November, 2018. He has been Vice President of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) and holds the position of President of the Central Research Institute, a division of SPH, since 2013. Dr. Liu serves as Chairman of the Board of Shanghai Jiaolian Medicine Research and Development Co., Ltd, a wholly owned subsidiary of SPH. From 2001 to 2012, Dr. Liu served as a Vice General Manager in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Dr. Liu holds a M.D. and a Ph.D. from Second Military Medical University in Shanghai, China. Dr. Liu’s extensive experience as a chairman, director, and senior management of international healthcare companies contributed to our board of directors’ conclusion that he should serve as a director of our company.